Key result
Depressive and anxiety symptoms correlate strongly with lower quality of life in CAD.
Why the study?
In patients with CHD, depression, anxiety, and differing coping strategies may adversely affect quality of life and psychological adjustment to chronic cardiac illness.
Cross-Sectional (n=120)
No
In patients with established coronary heart disease, clinically relevant depression (35.8%), anxiety (32.5%), and maladaptive coping are independently associated with poorer quality of life, while adaptive coping is associated with better quality of life.
Answers are grounded in this paper and cite their sources.
May warrant mental health assessment in CHD care; hypothesis-generating for whether interventions improve quality of life.
Background: Coronary heart disease (CHD) is a chronic cardiovascular condition whose impact extends beyond physical manifestations. Persistent concerns regarding recurrent cardiac events, functional limitations, treatment requirements, and long-term health may contribute to psychological distress. Depression and anxiety may adversely affect quality of life and influence how patients adapt to chronic cardiac illness. Coping strategies may further contribute to differences in psychological adjustment and perceived well-being. Methodology: A hospital-based cross-sectional observational study was conducted among 120 patients with established CHD at Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India, from 5 January 2025 to 31 October 2025. Sociodemographic and clinical information was collected using a structured proforma. Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9), anxiety using the Generalized Anxiety Disorder-7 (GAD-7), quality of life using the WHOQOL-BREF, and coping responses using the Brief COPE inventory. Associations between psychological symptoms, quality of life, and coping patterns were assessed using appropriate descriptive and inferential statistical methods. Multivariable linear regression was performed to identify factors independently associated with overall quality of life. Results: Among the 120 participants, the mean age was 57.6 ± 10.8 years, and 78 (65.0%) were males. Clinically relevant depressive symptoms (PHQ-9 ≥10) were identified in 43 (35.8%) participants, while clinically relevant anxiety symptoms (GAD-7 ≥10) were present in 39 (32.5%). Participants with clinically relevant depressive symptoms had significantly lower WHOQOL-BREF scores across the physical, psychological, social-relationship, and environmental domains (p≤0.001). Similarly, clinically relevant anxiety was associated with significantly poorer quality-of-life scores across all assessed domains (p≤0.004). PHQ-9 scores demonstrated a significant inverse correlation with overall quality of life (r = −0.62, p < 0.001), while GAD-7 scores showed a similar inverse correlation (r = −0.55, p < 0.001). Adaptive coping was positively associated with overall quality of life (r = 0.48, p < 0.001), whereas maladaptive coping showed an inverse association (r = −0.51, p < 0.001). In multivariable analysis, higher PHQ-9, GAD-7, and maladaptive coping scores were independently associated with poorer quality of life, whereas greater adaptive coping was associated with better quality-of-life scores. Conclusion: Psychological distress represents an important component of the overall burden experienced by patients with CHD. Depressive and anxiety symptoms were associated with poorer quality of life, while adaptive coping was associated with more favourable quality-of-life outcomes. These findings support the incorporation of psychological and coping assessment into comprehensive cardiovascular care to facilitate identification of patients who may benefit from additional psychosocial support. Recommendation: Routine screening for depressive and anxiety symptoms should be considered in patients with established CHD, particularly those experiencing persistent distress or impaired functioning. A multidisciplinary approach incorporating psychological counselling, social support, patient education, and coping-focused interventions may help address the psychosocial needs of patients with chronic coronary disease.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2026) conducted a cross-sectional in Coronary heart disease (n=120). Clinically relevant depressive symptoms (PHQ-9 ≥10) vs. No clinically relevant depressive symptoms (PHQ-9 <10) was evaluated on Overall quality of life (WHOQOL-BREF overall score) (β -0.41, 95% CI -0.78 to -0.04, p=<0.001). Depressive and anxiety symptoms inversely correlated with overall quality of life in coronary heart disease patients.
Synapse has enriched 10 related papers. Consider them for comparative context: